Zoetis Inc (NYSE:ZTS) – Investment analysts at Gabelli boosted their FY2018 earnings estimates for shares of Zoetis in a report issued on Friday. Gabelli analyst K. Kedra now forecasts that the company will earn $3.05 per share for the year, up from their prior estimate of $3.00. Gabelli also issued estimates for Zoetis’ FY2020 earnings at $3.90 EPS and FY2022 earnings at $4.75 EPS.
Zoetis (NYSE:ZTS) last issued its earnings results on Thursday, February 15th. The company reported $0.69 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.03. Zoetis had a net margin of 16.28% and a return on equity of 65.96%. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter last year, the firm posted $0.47 EPS. The business’s revenue for the quarter was up 14.3% compared to the same quarter last year.
Shares of Zoetis (NYSE:ZTS) traded down $0.10 during mid-day trading on Monday, hitting $79.63. 347,421 shares of the stock were exchanged, compared to its average volume of 2,996,829. Zoetis has a fifty-two week low of $52.25 and a fifty-two week high of $81.40. The company has a debt-to-equity ratio of 2.77, a quick ratio of 2.55 and a current ratio of 3.85. The stock has a market cap of $38,689.28, a P/E ratio of 45.63, a PEG ratio of 1.80 and a beta of 1.06.
Institutional investors have recently added to or reduced their stakes in the stock. Polen Capital Management LLC acquired a new position in Zoetis during the 4th quarter worth $285,967,000. Bessemer Group Inc. grew its holdings in Zoetis by 231,590.8% during the 4th quarter. Bessemer Group Inc. now owns 2,117,654 shares of the company’s stock worth $152,557,000 after acquiring an additional 2,116,740 shares in the last quarter. BlackRock Inc. grew its holdings in Zoetis by 3.8% during the 4th quarter. BlackRock Inc. now owns 38,485,542 shares of the company’s stock worth $2,772,498,000 after acquiring an additional 1,394,156 shares in the last quarter. Millennium Management LLC grew its holdings in Zoetis by 208.1% during the 4th quarter. Millennium Management LLC now owns 1,984,470 shares of the company’s stock worth $142,961,000 after acquiring an additional 1,340,378 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in Zoetis by 111.3% during the 4th quarter. Acadian Asset Management LLC now owns 1,709,352 shares of the company’s stock worth $123,143,000 after acquiring an additional 900,261 shares in the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, April 20th will be paid a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s dividend payout ratio (DPR) is 28.57%.
COPYRIGHT VIOLATION NOTICE: This story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2018/02/20/gabelli-weighs-in-on-zoetis-incs-fy2018-earnings-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.